-
1
-
-
84894277519
-
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
-
1 Damman, K., Valente, M.A.E., Voors, A.A., O'Connor, C.M., van Veldhuisen, D.J., Hillege, H.L., Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35 (2014), 455–469.
-
(2014)
Eur Heart J
, vol.35
, pp. 455-469
-
-
Damman, K.1
Valente, M.A.E.2
Voors, A.A.3
O'Connor, C.M.4
van Veldhuisen, D.J.5
Hillege, H.L.6
-
2
-
-
79952260198
-
Diuretic strategies in patients with acute decompensated heart failure
-
2 Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
-
(2011)
N Engl J Med
, vol.364
, pp. 797-805
-
-
Felker, G.M.1
Lee, K.L.2
Bull, D.A.3
Redfield, M.M.4
Stevenson, L.W.5
Goldsmith, S.R.6
-
3
-
-
84871058843
-
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
-
3 Bart, B.A., Goldsmith, S.R., Lee, K.L., Givertz, M.M., O'Connor, C.M., Bull, D.A., et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367 (2012), 2296–2304.
-
(2012)
N Engl J Med
, vol.367
, pp. 2296-2304
-
-
Bart, B.A.1
Goldsmith, S.R.2
Lee, K.L.3
Givertz, M.M.4
O'Connor, C.M.5
Bull, D.A.6
-
4
-
-
84890369206
-
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial
-
4 Chen, H.H., Anstrom, K.J., Givertz, M.M., Stevenson, L.W., Semigran, M.J., Goldsmith, S.R., et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310 (2013), 2533–2543.
-
(2013)
JAMA
, vol.310
, pp. 2533-2543
-
-
Chen, H.H.1
Anstrom, K.J.2
Givertz, M.M.3
Stevenson, L.W.4
Semigran, M.J.5
Goldsmith, S.R.6
-
5
-
-
77957730950
-
Committees PIa. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
5 Massie, B.M., O'Connor, C.M., Metra, M., Ponikowski, P., Teerlink, J.R., Cotter, G., et al. Committees PIa. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363 (2010), 1419–1428.
-
(2010)
N Engl J Med
, vol.363
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
Ponikowski, P.4
Teerlink, J.R.5
Cotter, G.6
-
6
-
-
84911004130
-
Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from ASCEND-HF
-
6 van Deursen, V.M., Hernandez, A.F., Stebbins, A., Hasselblad, V., Ezekowitz, J.A., Califf, R.M., et al. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from ASCEND-HF. Circulation 130 (2014), 958–965.
-
(2014)
Circulation
, vol.130
, pp. 958-965
-
-
van Deursen, V.M.1
Hernandez, A.F.2
Stebbins, A.3
Hasselblad, V.4
Ezekowitz, J.A.5
Califf, R.M.6
-
7
-
-
77954951329
-
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival
-
7 Testani, J.M., Chen, J., McCauley, B.D., Kimmel, S.E., Shannon, R.P., Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122 (2010), 265–272.
-
(2010)
Circulation
, vol.122
, pp. 265-272
-
-
Testani, J.M.1
Chen, J.2
McCauley, B.D.3
Kimmel, S.E.4
Shannon, R.P.5
-
8
-
-
84855590631
-
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction
-
8 Testani, J.M., Kimmel, S.E., Dries, D.L., Coca, S.G., Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail 4 (2011), 685–691.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 685-691
-
-
Testani, J.M.1
Kimmel, S.E.2
Dries, D.L.3
Coca, S.G.4
-
9
-
-
84890054407
-
Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study
-
9 Lesogor, A., Cohn, J.N., Latini, R., Tognoni, G., Krum, H., Massie, B., et al. Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study. Eur J Heart Fail 15 (2013), 1236–1244.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1236-1244
-
-
Lesogor, A.1
Cohn, J.N.2
Latini, R.3
Tognoni, G.4
Krum, H.5
Massie, B.6
-
10
-
-
84855939148
-
Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure
-
10 Testani, J.M., McCauley, B.D., Chen, J., Coca, S.G., Cappola, T.P., Kimmel, S.E., Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail 17 (2011), 993–1000.
-
(2011)
J Card Fail
, vol.17
, pp. 993-1000
-
-
Testani, J.M.1
McCauley, B.D.2
Chen, J.3
Coca, S.G.4
Cappola, T.P.5
Kimmel, S.E.6
-
11
-
-
84877300464
-
Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure
-
11 Brisco, M.A., Coca, S.G., Chen, J., Owens, A.T., McCauley, B.D., Kimmel, S.E., et al. Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail 6 (2013), 233–239.
-
(2013)
Circ Heart Fail
, vol.6
, pp. 233-239
-
-
Brisco, M.A.1
Coca, S.G.2
Chen, J.3
Owens, A.T.4
McCauley, B.D.5
Kimmel, S.E.6
-
12
-
-
84896108588
-
Prevalence and prognostic importance of changes in renal function after mechanical circulatory support
-
12 Brisco, M.A., Kimmel, S.E., Coca, S.G., Putt, M.E., Jessup, M., Tang, W.W., et al. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail 7 (2014), 68–75.
-
(2014)
Circ Heart Fail
, vol.7
, pp. 68-75
-
-
Brisco, M.A.1
Kimmel, S.E.2
Coca, S.G.3
Putt, M.E.4
Jessup, M.5
Tang, W.W.6
-
13
-
-
78649694220
-
Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure
-
13 Testani, J., McCauley, B., Kimmel, S., Shannon, R., Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. Am J Cardiol 106 (2010), 1763–1769.
-
(2010)
Am J Cardiol
, vol.106
, pp. 1763-1769
-
-
Testani, J.1
McCauley, B.2
Kimmel, S.3
Shannon, R.4
-
14
-
-
80155153008
-
Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials
-
14 Testani, J.M., Coca, S.G., Shannon, R.P., Kimmel, S.E., Cappola, T.P., Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials. Eur J Heart Fail 13 (2011), 1224–1230.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 1224-1230
-
-
Testani, J.M.1
Coca, S.G.2
Shannon, R.P.3
Kimmel, S.E.4
Cappola, T.P.5
-
15
-
-
84878324718
-
Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment
-
15 Dupont, M., Mullens, W., Finucan, M., Taylor, D.O., Starling, R.C., Tang, W.H., Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail 15 (2013), 433–440.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 433-440
-
-
Dupont, M.1
Mullens, W.2
Finucan, M.3
Taylor, D.O.4
Starling, R.C.5
Tang, W.H.6
-
16
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
16 Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F., Feldman, H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
-
(2009)
Ann Intern Med
, vol.150
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
Zhang, Y.L.4
Castro, A.F.5
Feldman, H.I.6
-
17
-
-
0021223213
-
Bumetanide and furosemide in heart failure
-
17 Brater, D.C., Day, B., Burdette, A., Anderson, S., Bumetanide and furosemide in heart failure. Kidney Int 26 (1984), 183–189.
-
(1984)
Kidney Int
, vol.26
, pp. 183-189
-
-
Brater, D.C.1
Day, B.2
Burdette, A.3
Anderson, S.4
-
18
-
-
0029030940
-
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure
-
18 Vargo, D.L., Kramer, W.G., Black, P.K., Smith, W.B., Serpas, T., Brater, D.C., Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 57 (1995), 601–609.
-
(1995)
Clin Pharmacol Ther
, vol.57
, pp. 601-609
-
-
Vargo, D.L.1
Kramer, W.G.2
Black, P.K.3
Smith, W.B.4
Serpas, T.5
Brater, D.C.6
-
19
-
-
0004154522
-
Brenner & Rector's The Kidney
-
Philadelphia, PA: Elsevier
-
19 Brenner, B., Rector, F., Brenner & Rector's The Kidney. Philadelphia, PA: Elsevier, 2008.
-
(2008)
-
-
Brenner, B.1
Rector, F.2
-
20
-
-
0024592074
-
The impact of confounder selection criteria on effect estimation
-
20 Mickey, R., Greenland, S., The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129 (1989), 125–137.
-
(1989)
Am J Epidemiol
, vol.129
, pp. 125-137
-
-
Mickey, R.1
Greenland, S.2
-
21
-
-
33646720277
-
Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)
-
21 Cowie, M., Komajda, M., Murray-Thomas, T., Underwood, J., Ticho, B., POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27 (2006), 1216–1222.
-
(2006)
Eur Heart J
, vol.27
, pp. 1216-1222
-
-
Cowie, M.1
Komajda, M.2
Murray-Thomas, T.3
Underwood, J.4
Ticho, B.5
-
22
-
-
9144262490
-
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
-
22 Forman, D., Butler, J., Wang, Y., Abraham, W., O'Connor, C., Gottlieb, S., et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43 (2004), 61–67.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 61-67
-
-
Forman, D.1
Butler, J.2
Wang, Y.3
Abraham, W.4
O'Connor, C.5
Gottlieb, S.6
-
23
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
23 O'Connor, C., Starling, R., Hernandez, A., Armstrong, P., Dickstein, K., Hasselblad, V., et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365 (2011), 32–43.
-
(2011)
N Engl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.1
Starling, R.2
Hernandez, A.3
Armstrong, P.4
Dickstein, K.5
Hasselblad, V.6
-
24
-
-
84907087561
-
Angiotensin-neprilysin inhibition versus enalapril in heart failure
-
24 McMurray, J.J., Packer, M., Desai, A.S., Gong, J., Lefkowitz, M.P., Rizkala, A.R., et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371 (2014), 993–1004.
-
(2014)
N Engl J Med
, vol.371
, pp. 993-1004
-
-
McMurray, J.J.1
Packer, M.2
Desai, A.S.3
Gong, J.4
Lefkowitz, M.P.5
Rizkala, A.R.6
-
25
-
-
0003077113
-
A regulatory authority's opinion about surrogate endpoints
-
W.S. Nimmo G.T. Tucker John Wiley & Sons Ltd. New York
-
25 Temple, R.J., A regulatory authority's opinion about surrogate endpoints. Nimmo, W.S., Tucker, G.T., (eds.) Clinical measurement in drug evaluation, 1995, John Wiley & Sons Ltd., New York.
-
(1995)
Clinical measurement in drug evaluation
-
-
Temple, R.J.1
-
26
-
-
0024520844
-
Surrogate endpoints in clinical trials: definition and operational criteria
-
26 Prentice, R.L., Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8 (1989), 431–440.
-
(1989)
Stat Med
, vol.8
, pp. 431-440
-
-
Prentice, R.L.1
-
27
-
-
84890946148
-
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease
-
27 de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G.L., Chin, M., Christ-Schmidt, H., et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369 (2013), 2492–2503.
-
(2013)
N Engl J Med
, vol.369
, pp. 2492-2503
-
-
de Zeeuw, D.1
Akizawa, T.2
Audhya, P.3
Bakris, G.L.4
Chin, M.5
Christ-Schmidt, H.6
|